Maternal and Perinatal Center, Tokyo Women's Medical University
Tokyo, 162-8666, Japan
NCT Number: NCT00565890
In order to determine the efficacy and safety of thyroxine replacement, a randomized clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the first month of age is conducted.
Looking for future studies?
Notify Me2 week–4 week
All sexes
Interventional
Not applicable
Tokyo, 162-8666, Japan
A prospective randomized unmasked controlled trial is conducted. Newborn infants with birth weight less than 1500g are randomized into thyroxine treatment or un-treatment group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
thyroxine at the dose of 5 μg/kg-wt /day
Time frame: 18 months
Time frame: 6 years
Time frame: 6 years
Time frame: 6 years
Time frame: 6 years
Tokyo Women's Medical University
Other
Randomized Controlled Clinical Trial of Thyroxine Supplementation for Very-low-birth-weight Infants With Hypothyroxinemia During the First Month of Age
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00388297
Endocrine System Diseases, Hypothyroxinemia
Birmingham, Alabama, United States
View Trial DetailsNCT01306227
Endocrine System Diseases, Female Urogenital Diseases and Pregnancy Complications
Caen, Basse Normandie, France
View Trial Details